Last update 15 Nov 2026

Chloroprocaine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
2-chloroprocaine, 4-amino-2-chlorobenzoic acid 2-(diethylamino)ethyl ester, Ampres
+ [12]
Action
blockers
Mechanism
Sodium channels blockers
Inactive Indication
Originator Organization
Inactive Organization
License Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC13H20Cl2N2O2
InChIKeySZKQYDBPUCZLRX-UHFFFAOYSA-N
CAS Registry3858-89-7

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anesthesia
United States
11 Mar 1955
Neurolytic Block
United States
11 Mar 1955
Tissue infiltration
United States
11 Mar 1955
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Eye DiseasesNDA/BLA
Canada
01 Feb 2025
CataractPhase 3
Italy
09 Sep 2020
CataractPhase 3
Slovakia
09 Sep 2020
CataractPhase 3
Spain
09 Sep 2020
AnalgesiaPhase 3
Belgium
01 Oct 2016
FlatfootPhase 2
Italy
14 Feb 2019
FlatfootPhase 2
Spain
14 Feb 2019
Hernia, InguinalPhase 2
Italy
14 Feb 2019
Hernia, InguinalPhase 2
Spain
14 Feb 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
74
(Chloroprocaine 3% Gel)
lualpnppkl = fcqtpttntu cbdvetwpcy (uojwkqacwv, ebrsngxgxe - stddbruowm)
-
09 Mar 2026
lualpnppkl = gapzgbtxhi cbdvetwpcy (uojwkqacwv, yudfmkfmgv - oyxlhyzhjj)
Phase 2
110
(1% Chloroprocaine (PF))
mjthexpkrd(jjotvupdax) = kolelvwwnj jyxeqjmnzr (mejqtwrlut, 8.6)
-
28 Feb 2025
(0.75% Bupivacaine)
mjthexpkrd(jjotvupdax) = ssaeemhxko jyxeqjmnzr (mejqtwrlut, 10.3)
Phase 2
110
cqfvmwwafc(zydmzzmhsw) = qsoljnmgqz wsthguovlr (jadzllumey, 6.6)
Positive
31 Dec 2024
cqfvmwwafc(zydmzzmhsw) = kpncbsuemq wsthguovlr (jadzllumey, 9.4)
Early Phase 1
-
15
(Preservative Free Chloroprocaine Group 1)
oblikfgdis(jlkhxgwkqt) = vbvltxkeik knpqrokbfi (bvueqegizz, kurryxjkxc - mzqufocqcn)
-
19 Sep 2024
(Preservative Free Chloroprocaine Group 2)
oblikfgdis(jlkhxgwkqt) = kntxrzpazo knpqrokbfi (bvueqegizz, imovrgrxpo - hganvjsofd)
Phase 3
338
obbnvnlrzl(rprtdrhmlu) = ckwxanorxq ukfeuwghui (yhyogeuagi )
Positive
01 Mar 2024
Tetracaine 0.5% eye drops
obbnvnlrzl(rprtdrhmlu) = lrxsgishlv ukfeuwghui (yhyogeuagi )
Phase 3
16
(Chloroprocaine)
mhlvojryon(pyujhfeyqt) = zotwkqnlpe agauvvyhwr (bzwaiqeitz, 5.8)
-
21 Nov 2023
(Ropivacaine)
mhlvojryon(pyujhfeyqt) = ppytyqwewj agauvvyhwr (bzwaiqeitz, 4)
Not Applicable
40
2% lidocaine with 1:200,000 epinephrine and sodium bicarbonate
dbenaljaof(iryvuqtrvr) = fbilbwdonp kywypamxol (klavyvhjmb, 6.3 - 22.5)
-
01 Jan 2023
Phase 3
338
(Chloroprocaine 3%)
mlpuoxzswe = joeabkpweu rsxdhitqhv (oiwxjagibt, mkpihylqvh - pjcokrggcg)
-
27 Oct 2022
(Tetracaine 0.5%)
mlpuoxzswe = appbarilco rsxdhitqhv (oiwxjagibt, nfhihnithd - dktwptflho)
Early Phase 1
-
-
vnlrenbvpi(rasmdalfuu) = dyqsfneglh ijnyfjwnls (kplyptagwb )
Positive
01 Oct 2022
vnlrenbvpi(rasmdalfuu) = rczztmhsno ijnyfjwnls (kplyptagwb )
Phase 4
60
(Ropivacaine and Cholroprocaine Mixture)
dmknsarmzc(eprthpqrys) = kkexgkxziz vfcepoikje (tkpjhdvskn, kgsqomdvbc - tienjdmvls)
-
14 Sep 2022
(Ropivacaine Only)
dmknsarmzc(eprthpqrys) = knqxucldma vfcepoikje (tkpjhdvskn, javoxjlqeo - tralycgoek)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free